About

Sandy Munro, PhD, Chief Inhalation Scientist at Phillips-Medisize, became part of the company through its acquisition of Vectura in early 2025. He had been at Vectura since 2008 in a variety of pharmaceutical development leadership roles that focused on dry powder inhaler and smart nebuliser product development, as well as leading novel inhaled technology development programmes and defining the company’s technology strategy.

Prior to Vectura, Dr Munro spent 20 years at GSK, joining as an analytical scientist in 1987 and progressing through a number of roles to become GSK’s Global Director of Inhaled Science and Technology. He holds a chemistry degree from the University of Edinburgh (UK) and a PhD in synthetic organic chemistry from the University of East Anglia (UK). He is an honorary life member of The Aerosol Society of Great Britain.